TSTickerStarGet alerts

Medicus Pharma Closes $4.25M Equity Financings and $10.5M Debt Exchange with Streeterville Capital

Medicus Pharma Ltd. announced the closing of $4.25 million in fixed-price equity financings priced at-the-market, including a $1.25 million private placement led by CEO and other insiders with $750,000 from the Executive Chairman and CEO, and approximately $3.0 million via a registered direct offering. The company also exchanged $10.5 million of outstanding indebtedness held by Streeterville Capital, LLC for 105,000 preferred shares carrying an 8% cumulative annual dividend payable in kind. The company believes...

Share this story

Key takeaways

  • $4.25 million total equity financing includes $1.25 million CEO-led private placement and approximately $3.0 million registered direct offering

  • Registered direct offering issued 97,973 common shares plus pre-funded warrants for 1,646,213 common shares at $1.72 per share

  • Private placement issued 726,730 common shares at $1.72 per share to insiders including 616,272 shares to related parties

  • $10.5 million debt exchange with Streeterville Capital exchanged for 105,000 preferred shares at $100 per share

  • Preferred shares carry 8% cumulative annual dividend payable in kind and are redeemable at company's option

  • Approximately $350,000 of common shares sold via ATM program since September 30, 2026

  • Company believes transactions restored shareholders' equity above Nasdaq $2.5 million threshold

Key metrics

Equity financing total2026-11-16
$4.25 million
Private placement amount2026-11-16
$1.25 million
CEO participation in private placement2026-11-16
$750,000
Registered direct offering amount2026-11-16
$3.0 million
Debt exchange amount2026-11-16
$10.5 million
Preferred shares issued in debt exchange2026-11-16
105,000 shares
Preferred share dividend rate
8%
Equity financing share price2026-11-16
$1.72

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow MDCX in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert